Filing Flows

Filing Flows › Tvardi Therapeutics (TVRD) › Who owns the stock

Who owns Tvardi Therapeutics (TVRD) stock

51 funds reported Tvardi Therapeutics (TVRD) shares in their latest 13F filings, worth $6.0M in all. The largest holder is Vanguard Group ($1.8M). Last quarter 17 funds added to their stakes and 39 cut them.

Largest holders of TVRD (13F)Largest holders of TVRD (13F)Vanguard Group$1.8MSlate Path Capital LP$1.3MVanguard Capital Management LLC$654KAmerican Financial Group$425KUBS Group AG$211KSilvercrest Asset Management Grou…$192KBlackRock$181KRenaissance Technologies LLC$174KGeode Capital Management, LLC$172KMorgan Stanley$148K

Largest holders (13F)

FundSharesValueChangeQuarter
Vanguard Group424,821$1.8Mincrease2025-12-31
Slate Path Capital LP704,118$1.3Munchanged2026-06-30
Vanguard Capital Management LLC344,382$654Kdecrease2026-06-30
American Financial Group223,659$425Kunchanged2026-06-30
UBS Group AG111,133$211Kincrease2026-06-30
Silvercrest Asset Management Group LLC101,034$192Kunchanged2026-06-30
BlackRock95,478$181Kdecrease2026-06-30
Renaissance Technologies LLC91,409$174Kdecrease2026-06-30
Geode Capital Management, LLC90,350$172Kdecrease2026-06-30
Morgan Stanley77,845$148Kincrease2026-06-30
Duncan Williams Asset Management, LLC63,241$120Kunchanged2026-06-30
Vanguard Fiduciary Trust44,710$85Kdecrease2026-06-30
Russell Investments Group43,228$82Kincrease2026-06-30
State Street33,900$64Kdecrease2026-06-30
Susquehanna International Group, LLP33,165$63Knew2026-06-30

Tvardi Therapeutics' latest quarter

Tvardi Therapeutics, Q1 2025: revenue $2.6M (+20% year over year), operating margin -92.9%, net loss $4.9M, operating cash flow −$4.7M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most TVRD stock?

By the latest 13F filings: Vanguard Group ($1.8M); Slate Path Capital LP ($1.3M); Vanguard Capital Management LLC ($654K); American Financial Group ($425K); UBS Group AG ($211K).

What is the short interest in TVRD?

375,939 shares were sold short at the 2026-10-15 settlement, 67.53% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.